Skip to content
Wednesday, October 28, 2026 · Today’s edition, 6:30 a.m. ETWed, Oct 28 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

Who holds NVAXNOVAVAX

7 funds on our shelf carry NOVAVAX — heaviest hand: PBE at 2.70% of its book.

FundWeightFund assetsShares held
PBEInvesco Biotechnology & Genome ETFACTIVE2.70%$423M1,240,199
IDNAiShares Genomics Immunology and Healthcare ETFINDEX1.37%$317M451,885
XBIState Street SPDR S&P Biotech ETFINDEX0.66%$10.3B7,501,632
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.10%$112M12,706
IBBiShares Biotechnology ETFINDEX0.10%$10.6B1,204,219
TECBiShares U.S. Tech Breakthrough Multisector ETFINDEX0.03%$520M15,231
VHTVanguard Health Care Index FundINDEX0.02%$19B427,775

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.